Sathyendranath Malli

Sathyendranath Malli

Auto-generated profile, based on publicly available information

Sathyendranath Malli

School of Information Science Manipal Karnataka 576104 Manipal Academy of Higher Education

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 32 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.

9 May 2026 in F1000Research
Verified
Journal Article
Open access
PDF file
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 32 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.

23 June 2026 in F1000Research
Verified
Journal Article
Open access
RRRinsy Rahman
Rinsy Rahman
DSDola Saha
Dola Saha
WDWinniecia Dkhar
Winniecia Dkhar
SMSathyendranath Malli
Sathyendranath Malli
NANeil Barnes Abraham
Neil Barnes Abraham
Background Breast cancer remains a significant global health concern, with over 7.8 million cases reported in the last five years. Early detection and accurate classification are crucial for reducing mortality rates and improving outcomes. Machine learning (ML) has emerged as a transformative tool in medical imaging, enabling more efficient and accurate diagnostic processes. Objective This study aims to develop a machine learning-based predictive model for early detection and classification of breast cancer using the Wisconsin Breast Cancer Diagnostic dataset. Methods The dataset, comprising 569 samples and 33 features derived from fine needle aspirate biopsy images, was pre-processed through data cleaning, normalization using the Robust Scaler, and feature selection. Five supervised ML algorithms—Logistic Regression, Support Vector Classification (SVC) with linear and radial basis function (RBF) kernels, Decision Tree, and Random Forest—were implemented. Models were evaluated using performance metrics, including accuracy, precision, sensitivity, specificity, and F1 scores. Results The SVC-RBF model demonstrated the highest accuracy (98.68%) and balanced performance across other metrics, making it the most effective classifier for distinguishing between benign and malignant tumors. Key features such as texture mean and area (worst) significantly contributed to classification accuracy. Conclusions This study highlights the potential of ML algorithms, particularly SVC-RBF, to revolutionize breast cancer diagnostics through improved accuracy and efficiency. Future research should validate these findings with diverse datasets and explore their integration into clinical workflows to enhance decision-making and patient care.